Log in
Enquire now
‌

Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT01684072
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT016840720
Health Conditions in Trial
Chickenpox
Chickenpox
0
Trial Recruitment Size
1,2000
Clinical Trial Start Date
2011
0
Primary Completion Date
2011
0
Study Completion Date
2012
0
Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Prevention0
Intervention Type
Biological0
Interventional Trial Phase
Phase 40
Official Name
Evaluation of Safety and Immunogenicity Receiving Live Attenuated Vaccine Against Varicella Without Gelatin0
Last Updated
September 12, 2012
0
Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Investigator0
Participant0

Other attributes

Intervention Treatment
vaccine with gelatin0
vaccine without gelatin0
Study summary

The purpose of this study is to observe the occurrence of adverse reaction and antibody positive rate, the elevated level of antibody,Geometric mean titer (GMT) between groups of live attenuated varicella vaccine without gelatin.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.